The Design and Methodology Core will assist investigators to design studies and to analyze data using a mixture of established and innovative techniques to examine questions related to influencing individualization of treatment for women with breast cancer. Core D will support investigators through consultation and collaboration, lead work-in-progress sessions, as well as development and maintenance of centralized resources related to design and methodology. An important goal of our Design and Methodology core is to conduct breast cancer translational biostatistical research, facilitating the movement of new methodological approaches into practice for current and future projects. The project has four specific aims.
Aim 1 focuses on the most obvious essential role of directing and supervising the analysis and methods used by the three projects.
Aim 2 is designed to promote and support ancillary and follow-on studies that might be suggested from the preliminary work, or new external research findings or policy developments, with the goal of providing additional benefits from the large and expensive data collection effort undertaken to carry out the three projects described.
In Aim 3, the investigators propose to do work on two applied statistical problems, identifying cutting edge developments in statistical and biostatistical fields and doing the necessary work to demonstrate that these methods can feasibly and practically answer methodological problems encountered by the projects in this program.
Aim 4, is designed to focus on building centralized resources and collaborative bridges, both within the Program projects and cores and more broadly to other groups at UM that are focusing on translational research methods to further enhance our ability to bring the right methods to apply to the right problems. Core D includes experienced personnel with skills in: 1) advanced biostatistical analysis including multilevel modeling, latent variables, missing data and causal inference;2) psychometric measurement of patient and provider beliefs and attitudes, behaviors, and quality of life;3) survey methodology;4) quality measurement and practice profiling;5) experimental, quasi-experimental and observational designs;6) technical aspects of managing large administrative and clinical databases.

Public Health Relevance

Results from this program will improve public health by addressing the challenges of individualizing care for women with breast cancer. This Core will focus on supervising and directing the analysis of the three projects that are designed to achieve this goal, as well as advancing innovative methods in population-based oncology outcomes research by facilitating the movement of new biostatistical and methodological approaches into practice.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA163233-03
Application #
8726345
Study Section
Special Emphasis Panel (ZCA1-RPRB-B)
Project Start
Project End
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
3
Fiscal Year
2014
Total Cost
$126,940
Indirect Cost
$45,065
Name
University of Michigan Ann Arbor
Department
Type
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Martinez, Kathryn A; Resnicow, Ken; Williams, Geoffrey C et al. (2016) Does physician communication style impact patient report of decision quality for breast cancer treatment? Patient Educ Couns 99:1947-1954
Wallner, Lauren P; Martinez, Kathryn A; Li, Yun et al. (2016) Use of Online Communication by Patients With Newly Diagnosed Breast Cancer During the Treatment Decision Process. JAMA Oncol 2:1654-1656
Kerber, Kevin A; Meurer, William J; Brown, Devin L et al. (2015) Stroke risk stratification in acute dizziness presentations: A prospective imaging-based study. Neurology 85:1869-78
Martinez, Kathryn A; Kurian, Allison W; Hawley, Sarah T et al. (2015) How can we best respect patient autonomy in breast cancer treatment decisions? Breast Cancer Manag 4:53-64
Katz, Steven J; Kurian, Allison W; Morrow, Monica (2015) Treatment Decision Making and Genetic Testing for Breast Cancer: Mainstreaming Mutations. JAMA 314:997-8
Shumway, Dean; Griffith, Kent A; Jagsi, Reshma et al. (2015) Psychometric properties of a brief measure of autonomy support in breast cancer patients. BMC Med Inform Decis Mak 15:51
Katz, Steven J (2014) Treatment decision aids are unlikely to cut healthcare costs. BMJ 348:g1172
Resnicow, Ken; Abrahamse, Paul; Tocco, Rachel S et al. (2014) Development and psychometric properties of a brief measure of subjective decision quality for breast cancer treatment. BMC Med Inform Decis Mak 14:110
Katz, Steven J; Belkora, Jeffrey; Elwyn, Glyn (2014) Shared decision making for treatment of cancer: challenges and opportunities. J Oncol Pract 10:206-8
Katz, Steven J; Hawley, Sarah (2014) Patient-physician shared decision making--reply. JAMA 311:864

Showing the most recent 10 out of 12 publications